The cost-effectiveness of risk-stratified breast cancer screening in the UK.

ABSTRACT:

Background

There has been growing interest in the UK and internationally of risk-stratified breast screening whereby individualised risk assessment may inform screening frequency, starting age, screening instrument used, or even decisions not to screen. This study evaluates the cost-effectiveness of eight proposals for risk-stratified screening regimens compared to both the current UK screening programme and no national screening.

Methods

A person-level microsimulation model was developed to estimate health-related quality of life, cancer survival and NHS costs over the lifetime of the female population eligible for screening in the UK.

Results

Compared with both the current screening programme and no screening, risk-stratified regimens generated additional costs and

SUBMITTER: Hill H 

PROVIDER: S-EPMC10667489 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature